Similar articles for PMID: 27056648

Year	Number of Results
1950	1
1954	1
1956	1
1957	2
1958	1
1959	1
1960	2
1961	2
1981	1
1986	1
1991	1
2000	1
2003	2
2004	1
2005	5
2006	7
2007	13
2008	9
2009	12
2010	14
2011	19
2012	18
2013	21
2014	26
2015	25
2016	33
2017	52
2018	33
2019	18
2020	14
2021	16
2022	14
2023	3
2024	0

1

Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.

Shanmugam E, Doss CR, George M, Jena A, Rajaram M, Ramaraj B, Anjaneyan K, Kanagesh B. Shanmugam E, et al. Indian Heart J. 2016 Apr;68 Suppl 1(Suppl 1):S15-21. doi: 10.1016/j.ihj.2015.07.006. Epub 2015 Nov 12. Indian Heart J. 2016. PMID: 27056648 Free PMC article. Clinical Trial.

2

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C; SALT Investigators. Schrier RW, et al. N Engl J Med. 2006 Nov 16;355(20):2099-112. doi: 10.1056/NEJMoa065181. Epub 2006 Nov 14. N Engl J Med. 2006. PMID: 17105757 Free article. Clinical Trial.

3

Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.

Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F. Chen S, et al. J Clin Pharmacol. 2014 Dec;54(12):1362-7. doi: 10.1002/jcph.342. J Clin Pharmacol. 2014. PMID: 24906029 Clinical Trial.

4

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Konstam MA, et al. JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319. Epub 2007 Mar 25. JAMA. 2007. PMID: 17384437 Clinical Trial.

5

Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.

Nemerovski C, Hutchinson DJ. Nemerovski C, et al. Clin Ther. 2010 Jun;32(6):1015-32. doi: 10.1016/j.clinthera.2010.06.015. Clin Ther. 2010. PMID: 20637957 Review.

6

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.

Gralla RJ, Ahmad F, Blais JD, Chiodo J 3rd, Zhou W, Glaser LA, Czerwiec FS. Gralla RJ, et al. Cancer Med. 2017 Apr;6(4):723-729. doi: 10.1002/cam4.805. Epub 2017 Mar 2. Cancer Med. 2017. PMID: 28251822 Free PMC article. Clinical Trial.

7

[The efficacy and safety of tolvaptan on treating heart failure patients with hyponatremia].

Li L, Bai H, Zhu WL; Tolvaptan Therapy in Hyponatremia with Heart Failure Collaborative Group. Li L, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Oct;39(10):936-40. Zhonghua Xin Xue Guan Bing Za Zhi. 2011. PMID: 22321279 Clinical Trial. Chinese.

8

Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).

Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS; Investigation of the Neurocognitive Impact of Sodium Improvement in Geriatric Hyponatremia: Efficacy and Safety of Tolvaptan (INSIGHT) Investigators. Verbalis JG, et al. Am J Kidney Dis. 2016 Jun;67(6):893-901. doi: 10.1053/j.ajkd.2015.12.024. Epub 2016 Feb 11. Am J Kidney Dis. 2016. PMID: 26874645 Clinical Trial.

9

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.

Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C; Tolvaptan Investigators. Gheorghiade M, et al. Circulation. 2003 Jun 3;107(21):2690-6. doi: 10.1161/01.CIR.0000070422.41439.04. Epub 2003 May 12. Circulation. 2003. PMID: 12742979 Clinical Trial.

10

Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.

Cárdenas A, Ginès P, Marotta P, Czerwiec F, Oyuang J, Guevara M, Afdhal NH. Cárdenas A, et al. J Hepatol. 2012 Mar;56(3):571-8. doi: 10.1016/j.jhep.2011.08.020. Epub 2011 Oct 23. J Hepatol. 2012. PMID: 22027579 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

316 results

Results by year